Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases	Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Immunoglobulin G4-Related Disease, Skin and Connective Tissue Diseases, Stomatognathic Diseases, acquired idiopathic inflammatory myopathy, anterior uveitis, autoimmune disease, cardiovascular disorder, eye disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, panuveitis, skin disorder, skin vascular disease, uveal disorder, uveitis, vascular disorder, vasculitis	Recruiting	Phase 2	2026-05-12		NCT06285539

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alfasigma S.p.A.	8
Autoimmune Research and Collaboration Hub	1
ReumaNederland	2
UMC Utrecht	140

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam UMC	Amsterdam	Netherlands	85
Erasmus MC	Rotterdam	Netherlands	57
HagaZiekenhuis	The Hague	Netherlands	18
Radboud University Medical Center	Nijmegen	Netherlands	40
University Medical Center	Utrecht	Netherlands	1
Zuyderland Medical Center	Heerlen	Netherlands	2